Stay updated on ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Sign up to get notified when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.

Latest updates to the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the expected study record, with a simple header and a Home link. This indicates the page is currently inaccessible due to permission restrictions rather than new content changes.SummaryDifference21%

- Check10 days agoChange DetectedThe ORACLE study page was updated with new investigator and site information, expanded cohort and eligibility details, and revised enrollment numbers, along with a new Terminated status indicator. These updates reflect substantial changes to the study's scope and governance as displayed on the page.SummaryDifference2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This signals a minor update to the page's release history.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer now shows Revision: v3.6.5. This replaces the previous v3.6.4 and indicates a newer build of the page content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer version of the page. This reflects a minor update or fix applied to the page's content.SummaryDifference0.0%

- Check88 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating an internal update to the study record’s revision. There is no evidence here of changes to the study details or user-visible content.SummaryDifference0.0%

Stay in the know with updates to ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ORACLE: Liquid Biopsy in Residual Cancer Clinical Trial page.